Cargando…

Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G

BACKGROUND: The classical method for detection of Lassa virus-specific antibodies is the immunofluorescence assay (IFA) using virus-infected cells as antigen. However, IFA requires laboratories of biosafety level 4 for assay production and an experienced investigator to interpret the fluorescence si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabriel, Martin, Adomeh, Donatus I., Ehimuan, Jacqueline, Oyakhilome, Jennifer, Omomoh, Emmanuel O., Ighodalo, Yemisi, Olokor, Thomas, Bonney, Kofi, Pahlmann, Meike, Emmerich, Petra, Lelke, Michaela, Brunotte, Linda, Ölschläger, Stephan, Thomé-Bolduan, Corinna, Becker-Ziaja, Beate, Busch, Carola, Odia, Ikponmwosa, Ogbaini-Emovon, Ephraim, Okokhere, Peter O., Okogbenin, Sylvanus A., Akpede, George O., Schmitz, Herbert, Asogun, Danny A., Günther, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892945/ https://www.ncbi.nlm.nih.gov/pubmed/29596412 http://dx.doi.org/10.1371/journal.pntd.0006361

Ejemplares similares

Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area
por: Akhuemokhan, Odigie C., et al.
Publicado: (2017)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria
por: Okogbenin, Sylvanus, et al.
Publicado: (2019)

Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation
por: Asogun, Danny A., et al.
Publicado: (2012)

Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications
por: Akpede, George O., et al.
Publicado: (2019)

Corrigendum: Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications
por: Akpede, George O., et al.
Publicado: (2019)

Acute Lassa Virus Encephalitis with Lassa Virus in the Cerebrospinal Fluid but Absent in the Blood: A Case Report with a Positive Outcome
por: Okokhere, Peter O., et al.
Publicado: (2018)

Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues
por: Port, Julia R., et al.
Publicado: (2020)

Hospital-Based Surveillance for Viral Hemorrhagic Fevers and Hepatitides in Ghana
por: Bonney, Joseph Humphrey Kofi, et al.
Publicado: (2013)

Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria
por: Ajogbasile, Fehintola V., et al.
Publicado: (2020)

The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection
por: Ibekwe, Titus S., et al.
Publicado: (2012)

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
por: Erameh, Cyril, et al.
Publicado: (2020)

One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria
por: Okogbenin, Esther O., et al.
Publicado: (2020)

Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
por: Boisen, Matthew L., et al.
Publicado: (2020)

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Sensorineural hearing loss in Lassa fever: two case reports
por: Okokhere, Peter O, et al.
Publicado: (2009)

Identification of Common CD8(+) T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
por: Sakabe, Saori, et al.
Publicado: (2020)

High crossreactivity of human T cell responses between Lassa virus lineages
por: Sullivan, Brian M., et al.
Publicado: (2020)

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
por: Groger, Mirjam, et al.
Publicado: (2022)

Lassa Fever, Nigeria, 2003 and 2004
por: Omilabu, Sunday Aremu, et al.
Publicado: (2005)

Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera
por: Deschermeier, Christina, et al.
Publicado: (2022)

Discovery of Novel Rhabdoviruses in the Blood of Healthy Individuals from West Africa
por: Stremlau, Matthew H., et al.
Publicado: (2015)

Genomic analysis of Lassa virus from the 2018 surge in Nigeria
por: Siddle, Katherine J., et al.
Publicado: (2018)

Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin
por: Emmerich, Petra, et al.
Publicado: (2021)

Lassa fever presenting as acute abdomen: a case series
por: Dongo, Andrew E, et al.
Publicado: (2013)

Aseptic Meningitis Caused by Lassa Virus: Case Series Report
por: Okokhere, Peter O., et al.
Publicado: (2016)

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)

Lassa Fever, Nigeria, 2005–2008
por: Ehichioya, Deborah U., et al.
Publicado: (2010)

Age and sex prevalence of infectious dermatoses among primary school children in a rural South-Eastern Nigerian community
por: Kalu, Eziyi Iche, et al.
Publicado: (2015)

Spatial and temporal evolution of Lassa virus in the natural host population in Upper Guinea
por: Fichet-Calvet, Elisabeth, et al.
Publicado: (2016)

Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials
por: Ölschläger, Stephan, et al.
Publicado: (2013)

Establishment of Recombinant Trisegmented Mopeia Virus Expressing Two Reporter Genes for Screening of Mammarenavirus Inhibitors
por: Oestereich, Lisa, et al.
Publicado: (2022)

Psychiatric manifestations and associated risk factors among hospitalised patients with COVID-19 in Edo State, Nigeria: a cross-sectional study
por: Okogbenin, Esther Osemudiamen, et al.
Publicado: (2022)

Atypical presentation of mpox in Irrua environs: a case report
por: Oiwoh, S. O., et al.
Publicado: (2023)

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
por: Olayinka, Adebola Tolulope, et al.
Publicado: (2022)

Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
por: Heinrich, Megan L., et al.
Publicado: (2020)

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections
por: Okogbenin, Sylvanus, et al.
Publicado: (2022)

Novel Arenavirus Sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: Implications for Evolution of Arenaviruses in Africa
por: Coulibaly-N'Golo, David, et al.
Publicado: (2011)

Increase in Lassa Fever Cases in Nigeria, January–March 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rv74vt7fk28qrnt3loaqdkp2kg